|
EP0863151A1
(en)
*
|
1997-02-12 |
1998-09-09 |
Akzo Nobel N.V. |
"Canine parvovirus dna vaccines"
|
|
CA2223029A1
(en)
|
1997-02-12 |
1998-08-12 |
Akzo Nobel Nv |
Canine parvovirus dna vaccines
|
|
US6770282B1
(en)
|
1998-10-23 |
2004-08-03 |
Heska Corporation |
Cationic lipid-mediated enhancement of nucleic acid immunization of cats
|
|
FR2794648B1
(fr)
*
|
1999-06-10 |
2003-03-07 |
Merial Sas |
Vaccins adn pour animaux de compagnie et de sport
|
|
EP1185662B1
(fr)
*
|
1999-06-10 |
2011-03-02 |
Merial |
Vaccins adn pour les chiens
|
|
EP1074625A3
(en)
|
1999-06-14 |
2002-01-02 |
Pfizer Products Inc. |
DNA vaccine against feline immunodeficiency virus
|
|
AU6683400A
(en)
*
|
1999-07-08 |
2001-01-30 |
Mologen Forschungs-, Entwicklungs- Und Vertriebs Gmbh |
Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat
|
|
FR2796396A1
(fr)
*
|
1999-07-16 |
2001-01-19 |
Merial Sas |
Gene de calicivirus felin et vaccin recombine les incorporant
|
|
FR2796397B1
(fr)
*
|
1999-07-16 |
2006-09-01 |
Merial Sas |
Genes de calicivirus felin et vaccins notamment vaccins recombines
|
|
US6541458B1
(en)
|
1999-07-16 |
2003-04-01 |
Merial |
Feline calicivirus genes and vaccines in particular recombinant vaccines
|
|
US7078388B2
(en)
|
2000-01-21 |
2006-07-18 |
Merial |
DNA vaccines for farm animals, in particular bovines and porcines
|
|
FR2829498B1
(fr)
*
|
2001-09-11 |
2003-11-28 |
Merial Sas |
Igf-1 comme adjuvant de vaccin felin, notamment contre les retrovirus felins
|
|
EP1553977B1
(de)
*
|
2002-09-23 |
2006-08-09 |
Mologen AG |
Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze
|
|
EP2390352A1
(en)
|
2003-03-18 |
2011-11-30 |
Quantum Genetics Ireland Limited |
Systems and methods for improving protein and milk production of dairy herds
|
|
US7468273B2
(en)
|
2003-05-01 |
2008-12-23 |
Meial Limited |
Canine GHRH gene, polypeptides and methods of use
|
|
EP1689858B1
(en)
|
2003-11-13 |
2013-05-15 |
University Of Georgia Research Foundation, Inc. |
Methods of characterizing infectious bursal disease virus
|
|
EP1718770B1
(en)
|
2004-02-19 |
2011-05-25 |
The Governors of the University of Alberta |
Leptin promoter polymorphisms and uses thereof
|
|
WO2006115843A2
(en)
|
2005-04-25 |
2006-11-02 |
Merial Limited |
Nipah virus vaccines
|
|
US20080241184A1
(en)
|
2005-08-25 |
2008-10-02 |
Jules Maarten Minke |
Canine influenza vaccines
|
|
EP3147296A1
(en)
|
2005-11-14 |
2017-03-29 |
Merial, Inc. |
Gene therapy for renal failure
|
|
US7771995B2
(en)
|
2005-11-14 |
2010-08-10 |
Merial Limited |
Plasmid encoding human BMP-7
|
|
US7862821B2
(en)
|
2006-06-01 |
2011-01-04 |
Merial Limited |
Recombinant vaccine against bluetongue virus
|
|
AU2007352618B2
(en)
|
2007-05-02 |
2013-07-18 |
Boehringer Ingelheim Animal Health USA Inc. |
DNA plasmids having improved expression and stability
|
|
KR101715418B1
(ko)
|
2009-04-03 |
2017-03-10 |
메리얼 인코포레이티드 |
뉴캐슬 질환 바이러스-벡터를 이용한 조류 백신
|
|
EP4014989A1
(en)
|
2010-08-31 |
2022-06-22 |
Boehringer Ingelheim Animal Health USA Inc. |
Newcastle disease virus vectored herpesvirus vaccines
|
|
WO2012090073A2
(en)
|
2010-12-30 |
2012-07-05 |
The Netherlands Cancer Institute |
Methods and compositions for predicting chemotherapy sensitivity
|
|
AU2012240240A1
(en)
|
2011-04-04 |
2013-05-09 |
Netherlands Cancer Institute |
Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
|
|
WO2012138789A2
(en)
|
2011-04-04 |
2012-10-11 |
Netherlands Cancer Institute |
Methods and compositions for predicting resistance to anticancer treatment
|
|
US9216213B2
(en)
|
2011-04-20 |
2015-12-22 |
Merial, Inc. |
Adjuvanted rabies vaccine with improved viscosity profile
|
|
AP2013007180A0
(en)
|
2011-04-25 |
2013-10-31 |
Advanced Bioscience Lab Inc |
Truncated HIV envelope proteins (ENV), methods andcompositions related thereto
|
|
EP2714077B1
(en)
|
2011-06-01 |
2018-02-28 |
Merial, Inc. |
Needle-free administration of prrsv vaccines
|
|
CA2844927C
(en)
|
2011-08-12 |
2017-10-31 |
Merial Limited |
Vacuum-assisted preservation of biological products, in particular of vaccines
|
|
WO2013093629A2
(en)
|
2011-12-20 |
2013-06-27 |
Netherlands Cancer Institute |
Modular vaccines, methods and compositions related thereto
|
|
WO2013138776A1
(en)
|
2012-03-16 |
2013-09-19 |
Merial Limited |
Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
|
|
HK1216006A1
(zh)
|
2013-03-12 |
2016-10-07 |
Boehringer Ingelheim Animal Health USA Inc. |
反向遺傳學施馬倫貝格病毒疫苗組合物，和其使用方法
|
|
WO2016073410A1
(en)
|
2014-11-03 |
2016-05-12 |
Merial, Inc. |
Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
|
|
RU2586504C1
(ru)
*
|
2015-04-29 |
2016-06-10 |
Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Саратовский государственный аграрный университет имени Н.И. Вавилова" |
Набор синтетических олигонуклеотидных праймеров и способ его применения для индикации вирусов иммунодефицита и лейкемии кошек в клиническом материале методом мультиплексной полимеразной цепной реакции
|
|
US9981033B2
(en)
|
2015-06-23 |
2018-05-29 |
Merial Inc. |
PRRSV minor protein-containing recombinant viral vectors and methods of making and use thereof
|
|
FR3044017B1
(fr)
*
|
2015-11-24 |
2019-05-03 |
Glaxosmithkline Intellectual Property Development Limited |
Procede de transfection transitoire pour la production retrovirale
|
|
JP7098521B2
(ja)
*
|
2015-11-24 |
2022-07-11 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド |
レトロウイルス産生のための安定な細胞株
|
|
CN112921122A
(zh)
*
|
2021-03-26 |
2021-06-08 |
广西大学 |
猫常见病毒多重pcr快速检测试剂盒及其引物组
|
|
CN112921123B
(zh)
*
|
2021-04-06 |
2022-11-04 |
中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） |
快速检测猫杯状病毒的方法及检测用引物和试剂盒
|
|
CN115894716B
(zh)
*
|
2022-11-23 |
2024-02-09 |
华中农业大学 |
一种重组融合蛋白纳米颗粒及其制备方法
|
|
CN116218889A
(zh)
*
|
2022-12-13 |
2023-06-06 |
浙江大学 |
一种表达猫细小病毒VP2蛋白的mRNA疫苗及其制备方法
|
|
CN116121282B
(zh)
*
|
2023-01-10 |
2023-09-22 |
浙江大学 |
一种表达猫疱疹病毒蛋白的mRNA疫苗及其制备方法
|